Argitalpenak (474) David Jiménez Castro argitalpenak

2024

  1. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

    Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152

  2. C-reactive Protein and Risk of Right Ventricular Dysfunction and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

    Archivos de Bronconeumologia, Vol. 60, Núm. 6, pp. 344-349

  3. Chronic thromboembolic pulmonary hypertension treatment and sex: Systematic review and meta-analysis

    Medicina Clinica

  4. Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis

    Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537

  5. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

    Journal of Thrombosis and Haemostasis

  6. Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review

    Seminars in Thrombosis and Hemostasis

  7. External validation of the PE-SARD risk score for predicting early bleeding in acute pulmonary embolism in the RIETE Registry

    Thrombosis Research, Vol. 235, pp. 22-31

  8. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications

    Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 5, pp. 773-789

  9. High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients with Acute Pulmonary Embolism

    JAMA Cardiology, Vol. 9, Núm. 1, pp. 64-70

  10. Impact of a pulmonary embolism response team (PERT) in the prognosis of patients with acute symptomatic pulmonary embolism

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 141-149

  11. Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registry

    Journal of Thrombosis and Thrombolysis, Vol. 57, Núm. 2, pp. 312-321

  12. Lung Cancer Related Thrombosis (LCART): Focus on Immune Checkpoint Blockade

    Cancers, Vol. 16, Núm. 2

  13. Obesity a Prognostic Marker in Intermediate-high risk Pulmonary Embolism (PE)? RIETE Registry Review

    Thrombosis Update

  14. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

    Nature Reviews Cardiology

  15. Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial

    Thrombosis Research, Vol. 235, pp. 79-87

  16. Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial

    Chest, Vol. 165, Núm. 3, pp. 673-681

  17. Pulmonary embolism: Put the sPESI into practice

    European Journal of Internal Medicine

  18. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

    eClinicalMedicine, Vol. 73

  19. Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism

    Thrombosis Research, Vol. 233, pp. 18-24

  20. Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry

    Thrombosis Research, Vol. 236, pp. 88-96